Meeting
2019 Genitourinary Cancers Symposium
“Management Migration” in United States patients diagnosed with localized prostate cancer from 2010-2015.
Authors
Santino Butler
Brigham and Women's Hospital, Boston, MA
Santino Butler , Idalid Ivy Franco , Amandeep R Mahal , Nina Niu Sanford , Quoc-Dien Trinh , Timothy Rebbeck , Paul L. Nguyen , Anthony Victor D'Amico , Brandon Arvin Virgil Mahal
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr 11)
DOI
10.1200/JCO.2019.37.7_suppl.11
Abstract #
11
Poster Bd #
A21
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Neoadjuvant pamiparib plus abiraterone and ADT for high-risk/very high-risk localized prostate cancer: Results of a prospective study.
First Author: Junlong Zhuang
Poster
2024 ASCO Genitourinary Cancers Symposium
Neoadjuvant darolutamide plus androgen deprivation therapy for high-risk/very high-risk localized prostate cancer: A multicenter, open-labeled, single-arm phase II trial.
First Author: Junlong Zhuang
Poster
2021 Genitourinary Cancers Symposium
Management of localized prostate cancer during the Covid-19 pandemic at a multidisciplinary cancer center in New York City, New York.
First Author: Andrew Wood
Poster
2020 ASCO Virtual Scientific Program
Obesity and metabolic syndrome correlate with a higher risk of biochemical recurrence in high risk and intermediate risk prostate cancer patients who underwent robotic-assisted laparoscopic prostatectomy.
First Author: Shifeng Mao